The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Subscribe To Our Newsletter & Stay Updated
